Celsius, Lucid And Signet Are Among Top 10 Mid-Cap Gainers Last Week (Mar 17-Mar 21): Are The Others In Your Portfolio? – Signet Jewelers (NYSE:SIG), Celsius Holdings (NASDAQ:CELH), Lucid Group (NASDAQ:LCID)

These ten mid-cap stocks were the best performers in the last week. Are they in your portfolio?
- Diginex Limited DGNX shares surged 108.29%, probably amid an overall rebound after investor uncertainty and several risk factors that led to markets entering correction territory last week.
- NextDecade Corporation NEXT shares escalated 25.07%. The company announced that the U.S. Court of Appeals for the D.C. Circuit Court issued a revision to the August 2024 judgment, removing vacatur risk on the Federal Energy Regulatory Commission’s order.
- Celsius Holdings Inc. CELH stock upped 21.60%, likely reacting to news that PepsiCo Inc. PEP is acquiring prebiotic soda brand Poppi for $1.95 billion.
- Signet Jewelers Ltd SIG stock jumped 21.08% after it reported fourth-quarter FY25 earnings results. Several analysts revised the stock’s price forecast.
- New Fortress Energy Inc. NFE shares escalated 20.63% amid weakness in the dollar after the U.S. launched strikes on Houthi targets. Additionally, strong Chinese economic data could be lifting the demand outlook.
- Millrose Properties, Inc. MRP shares jumped 16.61% after the company declared its inaugural dividend and issued a 2025 outlook.
- Arcutis Biotherapeutics, Inc. ARQT stock gained 16.35% last week after Health Canada approved its Zoryve cream for treating mild to moderate atopic dermatitis.
- Lucid Group Inc. LCID stock increased 15.79% after Morgan Stanley upgraded the stock from Underweight to Equal-Weight.
- Catalyst Pharmaceuticals CPRX stock upped 15.27%.
- StoneCo STNE shares were up 14.20% after the company reported better-than-expected fourth-quarter EPS and sales.
Photo by Around the World Photos on Shutterstock
Also Read:
Momentum13.08
Growth1.17
Quality98.19
Value13.00
Market News and Data brought to you by Benzinga APIs
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.